Cystic Fibrosis
📧 Sign up to get email alerts when something new happens for Cystic Fibrosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-07-12FDA Approved: PERTZYE — Supplemental Application (Digestive Care, Inc.)
The FDA approved a supplemental application for PERTZYE (pancrelipase) from Digestive Care, Inc.
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: Efficacy Study of IgY (Antibody Against Pseudomonas) in Cystic Fibrosis Patients [Phase 3]
A Phase 3 efficacy study evaluating IgY antibody against Pseudomonas in cystic fibrosis patients has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-05Clinical Trial Update: High Flow Nasal Oxygen for Children With Cystic Fibrosis Presenting With Respiratory Failure - a Randomized Controlled Study [NA]
A randomized controlled trial evaluating high-flow nasal oxygen in children with cystic fibrosis and respiratory failure was terminated; no …
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Disclosing a Cystic Fibrosis Diagnosis to a Dating Partner
Completed clinical trial examining disclosure of a cystic fibrosis diagnosis to a dating partner, sponsored by the National Human Genome Res…
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Tissue Collection From People With Cystic Fibrosis
NHLBI-sponsored clinical trial update on tissue collection from people with cystic fibrosis. The study status is completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Increased Vitamin D Reduces Pulmonary Exacerbations in CF
A completed clinical trial indicates that increasing vitamin D supplementation reduces pulmonary exacerbations in patients with cystic fibro…
-
CLINICAL_TRIALS trial_result · 2017-06-22Clinical Trial Update: Using Remote Telemonitoring to Detect Early Decline in Lung Function & Streamline Clinics in Adults With Cystic Fibrosis [NA]
A completed clinical trial evaluated the use of remote telemonitoring to detect early decline in lung function and streamline clinic visits …
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: Lung Clearance Index (LCI) in Pediatric Patients With Obstructive Lung Disease [NA]
A pediatric trial evaluating Lung Clearance Index in obstructive lung disease has been terminated; the update does not include results but l…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Vitamin D and Microbiota in Cystic Fibrosis [NA]
A completed clinical trial studied the relationship between vitamin D status and gut microbiota in cystic fibrosis patients.
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis [Phase 2]
Phase 2 trial evaluated an antioxidant-enriched multivitamin for reducing inflammation and oxidative stress in cystic fibrosis; results have…
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Phase I Randomized Study of Adeno-Associated Virus-CFTR Vector in Patients With Cystic Fibrosis [Phase 1]
Phase I randomized trial evaluating an adeno-associated virus-CFTR vector in cystic fibrosis patients; the study has completed.
-
FDA approval · 2017-05-29FDA Approved: TOBRAMYCIN INHALATION — Supplemental Application (Prasco, LLC)
FDA approved a supplemental application for Tobramycin Inhalation submitted by Prasco, LLC.
-
FDA approval · 2017-05-17FDA Approved: KALYDECO — Supplemental Application (Vertex Pharmaceuticals Incorporated)
FDA approved a supplemental application for KALYDECO (ivacaftor) submitted by Vertex Pharmaceuticals Incorporated.
-
FDA label_change · 2017-05-17FDA Approved: KALYDECO — Supplemental Application (Vertex Pharmaceuticals Incorporated)
FDA approved a supplemental application for KALYDECO (ivacaftor), resulting in a label change for the drug.
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung Disease
A completed Genentech-sponsored study assessing the variability of the 6-minute walk test in cystic fibrosis patients with advanced lung dis…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF) [Phase 2]
A Phase 2 trial evaluating early methicillin-resistant Staphylococcus aureus therapy in cystic fibrosis was terminated, with results posted …
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation [Phase 3]
Phase 3 rollover study evaluating ivacaftor in cystic fibrosis patients with CFTR mutations other than G551D; study completed and results po…
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: A Phase 3 Rollover Study of Lumacaftor in Combination With Ivacaftor in Subjects 12 Years and Older With Cystic Fibrosis [Phase 3]
Phase 3 rollover trial evaluating lumacaftor in combination with ivacaftor in individuals 12 years and older with cystic fibrosis; the study…
-
CLINICAL_TRIALS research · 2017-05-10Clinical Trial Update: Exercise Capacity in Patients With Cystic Fibrosis vs. Non-cystic Fibrosis Bronchiectasis
A clinical trial update comparing exercise capacity in patients with cystic fibrosis versus those with bronchiectasis. The trial status is u…
-
CLINICAL_TRIALS research · 2017-05-10Clinical Trial Update: Effect of a Nursing Program for Patients With Cystic Fibrosis on Disease Management [NA]
A clinical trial evaluating the effect of a nursing program on disease management for patients with cystic fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Eficacy of Long-term Suplementation With Docosahexaenoic Acid in Patients With Cystic Fibrosis [NA]
This clinical trial update reports on the efficacy of long-term docosahexaenoic acid supplementation in patients with cystic fibrosis.
-
CLINICAL_TRIALS research · 2017-04-20Clinical Trial Update: A Study Comparing Continuous Infusion Antibiotics to Standard Treatment for Lung Infections in Cystic Fibrosis [Phase 4]
This is an update on a Phase 4 clinical trial comparing continuous infusion antibiotics to standard treatment for lung infections in cystic …
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Population Pharmacokinetics and Safety of Intravenous Ceftolozane/Tazobactam in Adult Cystic Fibrosis Patients [Phase 4]
Phase 4 trial evaluating population pharmacokinetics and safety of intravenous ceftolozane/tazobactam in adult cystic fibrosis patients, com…
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: A Coaching Intervention to Young Adults With Cystic Fibrosis [NA]
This entry reports the completion of a clinical trial testing a coaching intervention for young adults with cystic fibrosis, conducted in De…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Do More, B'More, Live Fit [NA]
This ClinicalTrials.gov update indicates that the Johns Hopkins University study 'Do More, B'More, Live Fit' (NCT03109912) focusing on cysti…